dronabinol has been researched along with Anochlesia in 88 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (31.82) | 18.7374 |
| 1990's | 26 (29.55) | 18.2507 |
| 2000's | 16 (18.18) | 29.6817 |
| 2010's | 15 (17.05) | 24.3611 |
| 2020's | 3 (3.41) | 2.80 |
| Authors | Studies |
|---|---|
| Audette, CA; Breuer, A; Burstein, SH; Colodner, S; Devane, WA; Doyle, SA; Mechoulam, R | 1 |
| Compton, DR; Khanolkar, AD; Makriyannis, A; Martin, BR; Yan, G; Yin, D | 1 |
| Barg, J; Bayewitch, M; Breuer, A; Hanus, L; Levy, R; Mechoulam, R; Rhee, MH; Vogel, Z | 1 |
| Moore, CF; Weerts, EM | 1 |
| Breuer, A; Colodete, DAE; Cortez, I; Del-Bel, EA; Fogaça, MV; Gomes, FV; Guimarães, FS; Mechoulam, R; Pedrazzi, JFC; Silva, NR | 1 |
| De Giacomo, V; Häring, M; Lutz, B; Remmers, F; Ruehle, S | 1 |
| Grel, A; Metna-Laurent, M; Mondésir, M; Piazza, PV; Vallée, M | 1 |
| Egashira, N; Iwasaki, K; Kinjo, J; Koushi, E; Mishima, K; Morimoto, S; Myose, T; Tanaka, H; Tanoue, A; Tsuchihashi, R | 1 |
| Carreira, EM; Chicca, A; Erni, R; Gertsch, J; Petrucci, V; Reynoso-Moreno, I; Schafroth, MA | 1 |
| Cole, EC; Kinsey, SG | 1 |
| Abdelrahman, M; Gamage, TF; Greig, IR; Ignatowska-Jankowska, BM; Lichtman, AH; Pertwee, RG; Poklis, J; Ross, RA; Thakur, GA; Tichkule, R; Trembleau, L; Wiley, JL | 1 |
| Craft, RM; McBride, AA; Vaughn, LK; Wakley, AA | 1 |
| Craft, RM; Wakley, AA; Wiley, JL | 1 |
| Antonazzo, KR; Cortes, RA; Grabenauer, M; Lefever, TW; Marusich, JA; Moore, KN; Patel, PR; Thomas, BF; Wallgren, MT; Wiley, JL | 1 |
| Borea, PA; Canazza, I; De Luca, MA; Di Rosa, F; Fantinati, A; Gregori, A; Margiani, G; Marti, M; Ossato, A; Rimondo, C; Serpelloni, G; Trapella, C; Varani, K; Vincenzi, F | 1 |
| Clowers, BH; Craft, RM; Haas, AE; Wiley, JL; Yu, Z | 1 |
| Evans, RL; Wiley, JL | 1 |
| Arnold, JC; Chesworth, R; Huang, XF; Karl, T; Long, LE; McGregor, IS | 1 |
| Ahmed, S; El-Alfy, AT; ElSohly, M; Ivey, K; Khan, I; Radwan, M; Robinson, K; Ross, S; Slade, D | 1 |
| DeLong, GT; Lichtman, AH; Poklis, A; Wolf, CE | 1 |
| Bosier, B; Hermans, E; Lambert, DM; Michotte, Y; Sarre, S; Smolders, I | 1 |
| Bohn, LM; Nguyen, PT; Raehal, KM; Schmid, CL; Selley, DE; Sim-Selley, LJ | 1 |
| Casti, P; Casu, G; Marchese, G; Pani, L; Ruiu, S; Saba, P; Sanna, A | 1 |
| Craft, RM; Tseng, AH | 1 |
| Craft, RM; Harding, JW; Tseng, AH | 1 |
| Bridgen, DT; Lichtman, AH; Martin, BR; Tao, Q; Thomas, BF; Varvel, SA | 1 |
| Brain, C; Chen, A; Courade, JP; Dyson, A; Fox, A; Groarke, A; Loong, Y; Peacock, M; Yaqoob, M | 1 |
| Bridgen, DT; Lichtman, AH; Long, K; Martin, BR; Varvel, SA; Wiley, JL; Yang, R | 1 |
| Egashira, N; Fujiwara, M; Iwasaki, K; Koushi, E; Matsuda, T; Mishima, K; Shoyama, Y | 1 |
| Koek, W; McMahon, LR | 1 |
| Craft, RM; Leitl, MD | 1 |
| Blaudzun, H; Kaiser, N; Lemberger, T; Lutz, B; Marsicano, G; Massa, F; Monory, K; Schütz, G; Wotjak, CT | 1 |
| Egashira, N; Egawa, T; Fujiwara, M; Hayakawa, K; Hazekawa, M; Irie, K; Iwasaki, K; Kitamura, Y; Mishima, K; Nishimura, R; Orito, K; Sano, K; Uchida, N | 1 |
| Egashira, N; Egawa, T; Fujiwara, M; Irie, K; Iwasaki, K; Katsurabayashi, S; Kitamura, Y; Koushi, E; Mishima, K; Nishimura, R; Orito, K; Sano, K; Takasaki, K; Uchida, N | 1 |
| Oguri, K; Watanabe, K; Yamamoto, I; Yoshimura, H | 1 |
| Fairbairn, JW; Pickens, JT | 3 |
| Carlsson, S; Ohlsson, A; Ryman, T; Strid, C; Widman, M | 1 |
| McMaster, SB; Moss, DE; Rogers, J | 1 |
| Narimatsu, S; Watanabe, K; Yamamoto, I; Yoshimura, H | 1 |
| Watanabe, K; Yamamoto, I; Yoshimura, H | 1 |
| Dalton, WS; Forney, RB; Johnson, JM; Lemberger, L; Maskarinec, MP; Novotny, M | 1 |
| Friedman, H; Gibertini, M; Klein, TW; Newton, C | 1 |
| Compton, DR; Martin, BR; Razdan, RK; Ryan, W; Singer, M | 1 |
| Dai, D; Duncan, SG; Huffman, JW; Jordan, RD; Lainton, JA | 1 |
| Hasegawa, T; Kameyama, T; Katsumata, Y; Kinoshita, H; Nabeshima, T; Yamamoto, I | 1 |
| Martín Calderón, JL; Mechoulam, R; Navarro, M; Rodríguez de Fonseca, F | 1 |
| Hasegawa, T; Kameyama, T; Kinoshita, H; Nabeshima, T; Yamamoto, I | 1 |
| Pertwee, RG; Wickens, AP | 2 |
| Gohda, H; Matsunaga, T; Nagai, K; Narimatsu, S; Watanabe, K; Yamamoto, I; Yoshimura, H | 1 |
| Matsunaga, T; Nagai, K; Watanabe, K; Yamamoto, I; Yoshimura, H | 1 |
| Chakrabarti, A; Chaudhuri, G; Gwebu, ET; Onaivi, ES | 1 |
| Dombrowski, DS; Pugh, G; Smith, PB; Welch, SP | 1 |
| Balster, RL; Compton, DR; Dutta, A; Gordon, PM; Lichtman, AH; Martin, BR; Razdan, RK; Siegel, C; Singer, M; Wiley, JL | 1 |
| Bar-Joseph, A; Berkovitch, Y; Biegon, A; Striem, S | 1 |
| Kimura, T; Kobana, K; Usami, N; Watanabe, K; Yamamoto, I; Yoshida, H; Yoshimura, H | 1 |
| Iversen, L | 1 |
| French, ED; Wu, X | 1 |
| Fernandez-Ruiz, JJ; Romero, J; Sañudo-Peña, MC; Seale, GE; Walker, JM | 1 |
| Bonner, T; Buckley, NE; Felder, CC; Glass, M; McCoy, KL; Mezey, E; Zimmer, A | 1 |
| Gough, AL; Olley, JE | 2 |
| Fujiwara, M; Oguri, K; Ueki, S; Watanabe, K; Yoshimura, H | 1 |
| Edery, H; Gottesfeld, Z | 1 |
| Gold, LH; Martin, BR; Prescott, WR | 1 |
| Martin, BR; Smith, PB | 1 |
| Martin, BR; Prescott, WR; Zhu, M | 1 |
| Pertwee, RG; Ross, TM | 1 |
| Martin, BR; Prescott, WR | 1 |
| Banijamali, A; Charalambous, A; Compton, DR; Friend, FL; Lin, S; Makriyannis, A; Marciniak, G; Martin, BR | 1 |
| Audette, CA; Burstein, SH; Doyle, SA; Hunter, SA | 1 |
| Burstein, SH; Hull, K; Hunter, SA; Shilstone, J | 1 |
| Compton, DR; Little, PJ; Martin, BR; Mechoulam, R | 1 |
| Gao, XK; Song, B | 1 |
| Greentree, SG; Pertwee, RG | 1 |
| Greentree, SG; Pertwee, RG; Swift, PA | 1 |
| Evans, AT; Evans, FJ; Formukong, EA | 1 |
| Matsubara, K; Narimatsu, S; Shimonishi, T; Watanabe, K; Yamamoto, I; Yoshimura, H | 1 |
| Fujiwara, M; Kiyota, Y; Ohta, H; Sakurai, Y; Shibata, S; Shimazoe, T; Ueki, S | 1 |
| Razdan, RK | 1 |
| Fujiwara, M; Kataoka, Y; Ohta, H; Oishi, R; Ueki, S | 1 |
| Burstein, S; Hunter, SA; Latham, V; Renzulli, L | 1 |
| Fernandes, M; Hill, R | 1 |
| Coper, H; Fernandes, M; Hill, R; Schabarek, A | 1 |
| Gill, EW; Jones, G | 1 |
| Howes, JF | 1 |
1 review(s) available for dronabinol and Anochlesia
| Article | Year |
|---|---|
Structure-activity relationships in cannabinoids.
Topics: Animals; Ataxia; Behavior, Animal; Body Temperature; Cannabinoids; Catalepsy; Discrimination, Psychological; Dronabinol; Humans; Motor Activity; Seizures; Structure-Activity Relationship | 1986 |
87 other study(ies) available for dronabinol and Anochlesia
| Article | Year |
|---|---|
Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities.
Topics: Analgesia; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Cannabinoids; Catalepsy; Cell Adhesion; Edema; Female; Leukocytes; Mice; Pain Measurement; Stereoisomerism; Structure-Activity Relationship | 1992 |
Synthesis and pharmacological properties of 11-hydroxy-3-(1',1'-dimethylheptyl)hexahydrocannabinol: a high-affinity cannabinoid agonist.
Topics: Analgesia; Animals; Body Temperature; Cannabinoids; Cannabinol; Catalepsy; Chromatography, High Pressure Liquid; Dronabinol; Mice; Motor Activity; Stereoisomerism; Structure-Activity Relationship | 1994 |
Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.
Topics: Adenylyl Cyclase Inhibitors; Animals; Brain; Cannabinoids; Cannabinol; Catalepsy; CHO Cells; COS Cells; Cricetinae; Enzyme Inhibitors; Humans; Kinetics; Mice; Models, Chemical; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship; Synaptosomes; Transfection | 1997 |
Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.
Topics: Animals; Cannabidiol; Cannabinoids; Cannabis; Catalepsy; Dronabinol; Female; Male; Pain; Rats; Rats, Sprague-Dawley | 2022 |
Behavioral effects induced by the cannabidiol analogs HU-502 and HU-556.
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Cannabidiol; Cannabinoids; Catalepsy; Dronabinol; Male; Mice | 2023 |
Differential glutamatergic and GABAergic contributions to the tetrad effects of Δ
Topics: Analgesia; Animals; Cannabinoid Receptor Agonists; Catalepsy; Dronabinol; Excitatory Amino Acid Agonists; GABA Agonists; Locomotion; Male; Mice; Mice, Knockout; Receptor, Cannabinoid, CB1; Receptors, GABA; Receptors, Glutamate | 2020 |
Cannabinoid-Induced Tetrad in Mice.
Topics: Animals; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Catalepsy; Disease Models, Animal; Dronabinol; Exploratory Behavior; Hypothermia; Male; Mice; Mice, Inbred C57BL; Movement Disorders; Piperidines; Pyrazoles; Rimonabant | 2017 |
Role of vasopressin V1a receptor in ∆
Topics: Animals; Cannabinoid Receptor Agonists; Cannabinoids; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Haloperidol; Immobilization; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Random Allocation; Receptors, Vasopressin | 2017 |
Uncovering the psychoactivity of a cannabinoid from liverworts associated with a legal high.
Topics: Analgesics; Animals; Biological Availability; Brain; Cannabinoids; Catalepsy; CHO Cells; Cricetulus; Dronabinol; Endocannabinoids; Enzymes; Hepatophyta; Hypothermia; Male; Mice, Inbred BALB C; Receptors, Cannabinoid; Stereoisomerism | 2018 |
Acute Δ(9)-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Catalepsy; Diclofenac; Dronabinol; Gastrointestinal Hemorrhage; Hypothermia; Locomotion; Male; Mice; Mice, Inbred C57BL | 2013 |
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569.
Topics: Allosteric Regulation; Amidohydrolases; Animals; Arachidonic Acids; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Catalepsy; Cyclohexanols; Dronabinol; Drug Evaluation; Eating; Endocannabinoids; Female; Hypothermia; Indoles; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Nociception; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2014 |
Cyclic ovarian hormone modulation of supraspinal Δ9-tetrahydrocannabinol-induced antinociception and cannabinoid receptor binding in the female rat.
Topics: Analgesics; Animals; Catalepsy; Dronabinol; Female; Gonadal Steroid Hormones; Locomotion; Organ Size; Ovary; Protein Binding; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Uterus; Vagina | 2014 |
Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat.
Topics: Analgesics; Animals; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Estrous Cycle; Female; Locomotion; Male; Pain Measurement; Rats; Sex Characteristics | 2014 |
AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
Topics: Analgesics; Animals; Cannabinoids; Catalepsy; Dronabinol; Endocannabinoids; Hydroxylation; Hypothermia; Illicit Drugs; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Motor Activity; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2015 |
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.
Topics: Adamantane; Aggression; Animals; Behavior, Animal; Binding, Competitive; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cannabis; Catalepsy; Dopamine; Dronabinol; Humans; In Vitro Techniques; Indazoles; Indoles; Male; Mice; Motor Activity; Naphthalenes; Nucleus Accumbens; Pain Threshold; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Reflex, Abnormal; Seizures | 2016 |
Gonadal hormone modulation of ∆
Topics: Analgesics; Animals; Catalepsy; Dronabinol; Drug Interactions; Estradiol; Female; Male; Proadifen; Rats; Sex Characteristics; Testosterone | 2017 |
To breed or not to breed? Empirical evaluation of drug effects in adolescent rats.
Topics: Aging; Animals; Antipsychotic Agents; Breeding; Catalepsy; Clozapine; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Environment; Female; Haloperidol; Male; Motor Activity; Neuropharmacology; Pain Threshold; Psychotropic Drugs; Rats; Rats, Long-Evans; Sex Characteristics; Stress, Psychological | 2009 |
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Behavior, Animal; Cannabidiol; Catalepsy; Dronabinol; Hypothermia; Interpersonal Relations; Male; Mice; Mice, Inbred C57BL; Motor Activity; Pain Measurement; Photoperiod; Psychotropic Drugs; Rats; Rats, Wistar; Schizophrenia; Schizophrenic Psychology; Sensory Gating; Time Factors | 2010 |
Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.
Topics: Animals; Antidepressive Agents; Cannabidiol; Cannabinoids; Cannabis; Catalepsy; Depression; Dose-Response Relationship, Drug; Dronabinol; Hindlimb Suspension; Hypothermia; Immobility Response, Tonic; Male; Mice; Random Allocation; Swimming | 2010 |
Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Camphanes; Cannabinoids; Cannabis; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Hallucinogens; Hypothermia; Inflammation; Male; Mice; Mice, Inbred ICR; Motor Activity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant | 2010 |
Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cannabinoids; Catalepsy; Cyclohexanols; Dronabinol; Male; Motor Activity; Rats; Rats, Wistar; Time Factors | 2010 |
β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.
Topics: Animals; Arrestins; Autoradiography; beta-Arrestins; Catalepsy; Central Nervous System; Down-Regulation; Dronabinol; Drug Tolerance; G-Protein-Coupled Receptor Kinases; Guanosine 5'-O-(3-Thiotriphosphate); Hypothermia; Mice; Mice, Knockout; Nociception; Receptor, Cannabinoid, CB1; Signal Transduction; Sulfur Radioisotopes | 2012 |
Haloperidol, but not clozapine, produces dramatic catalepsy in delta9-THC-treated rats: possible clinical implications.
Topics: Animals; Catalepsy; Clozapine; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Haloperidol; Male; Protein Binding; Rats; Rats, Sprague-Dawley | 2003 |
CB(1) receptor mediation of cannabinoid behavioral effects in male and female rats.
Topics: Analgesics; Animals; Catalepsy; Dronabinol; Female; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Sex Factors | 2004 |
Pharmacokinetic factors in sex differences in Delta 9-tetrahydrocannabinol-induced behavioral effects in rats.
Topics: Analgesics, Non-Narcotic; Analysis of Variance; Animals; Brain; Catalepsy; Dronabinol; Enzyme Inhibitors; Female; Male; Proadifen; Rats; Rats, Sprague-Dawley; Sex Factors; Spinal Cord | 2004 |
Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
Topics: Analgesics; Animals; Behavior, Animal; Body Temperature; Brain; Cannabis; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Inhalation Exposure; Injections, Intravenous; Male; Mice; Mice, Inbred ICR; Pain Measurement; Piperidines; Pyrazoles; Rimonabant; Smoke | 2005 |
Antihyperalgesic properties of the cannabinoid CT-3 in chronic neuropathic and inflammatory pain states in the rat.
Topics: Analgesics; Animals; Benzoxazines; Cannabinoids; Catalepsy; Cell Line; Chromatography; Cricetinae; Cricetulus; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Freund's Adjuvant; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Hypothermia; Inflammation; Ligation; Male; Morpholines; Motor Activity; Naphthalenes; Pain; Pain Measurement; Pain Threshold; Radioligand Assay; Rats; Rats, Wistar; Rotarod Performance Test; Sciatic Neuropathy; Sulfur Isotopes; Time Factors; Tritium | 2005 |
Interactions between THC and cannabidiol in mouse models of cannabinoid activity.
Topics: Animals; Body Temperature Regulation; Brain; Cannabidiol; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Inhalation Exposure; Injections, Intravenous; Male; Marijuana Smoking; Mice; Mice, Inbred ICR; Models, Animal; Motor Activity; Pain Threshold | 2006 |
Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Hallucinogens; Male; Mice; Motor Activity; Phenols; Piperazines; Postural Balance; Pyridines; Receptor, Serotonin, 5-HT1A; Serotonin Antagonists; Serotonin Receptor Agonists; Sulfonamides | 2006 |
Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
Topics: Animals; Benzoxazines; Cannabinoids; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Hypothermia; Injections, Intraperitoneal; Mice; Mice, Inbred C57BL; Morpholines; Motor Activity; Naphthalenes; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Time Factors | 2007 |
Gonadal hormone modulation of the behavioral effects of Delta9-tetrahydrocannabinol in male and female rats.
Topics: Analgesics, Non-Narcotic; Animals; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Estradiol; Estrous Cycle; Female; Male; Motor Activity; Orchiectomy; Ovariectomy; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Sex Factors; Testosterone | 2008 |
Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice.
Topics: Animals; Autonomic Nervous System; Behavior, Animal; Body Temperature; Catalepsy; Corpus Striatum; Dronabinol; gamma-Aminobutyric Acid; Gene Expression; Gene Silencing; Glutamic Acid; Interneurons; Male; Mice; Mice, Knockout; Motor Activity; Neocortex; Nociceptors; Pain Threshold; Psychotropic Drugs; Receptor, Cannabinoid, CB1 | 2007 |
Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
Topics: Animals; Body Temperature; Brain; Cannabidiol; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Hypothermia; Male; Maze Learning; Memory Disorders; Mice; Motor Activity; Psychotropic Drugs; Receptor, Cannabinoid, CB1 | 2008 |
Delta 9-tetrahydrocannabinol-induced catalepsy-like immobilization is mediated by decreased 5-HT neurotransmission in the nucleus accumbens due to the action of glutamate-containing neurons.
Topics: Acoustic Stimulation; Amantadine; Animals; Catalepsy; Dizocilpine Maleate; Dopamine Agents; Dronabinol; Excitatory Amino Acid Antagonists; Extracellular Space; Glutamic Acid; Hallucinogens; Male; Microinjections; Neurons; Nucleus Accumbens; Physical Stimulation; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, N-Methyl-D-Aspartate; Rimonabant; Serotonin; Serotonin Receptor Agonists; Synaptic Transmission | 2008 |
Comparison in mice of pharmacological effects of delta 8-tetrahydrocannabinol and its metabolites oxidized at 11-position.
Topics: Animals; Body Temperature; Catalepsy; Dronabinol; Humans; Lethal Dose 50; Male; Mice; Oxidation-Reduction; Pentobarbital; Sleep; Time Factors | 1980 |
The effect of conditions influencing endogenous prostaglandins on the activity of delta'-tetrahydrocannabinol in mice.
Topics: Animals; Catalepsy; Cold Temperature; Diet; Dietary Fats; Dronabinol; Female; Humans; Mice; Mycoses; Prostaglandins | 1980 |
Plasma and brain levels of delta 6-THC and seven monooxygenated metabolites correlated to the cataleptic effect in the mouse.
Topics: Animals; Behavior, Animal; Biotransformation; Brain; Cannabinoids; Catalepsy; Dronabinol; Female; Humans; Mice; Oxidation-Reduction | 1980 |
Activity of cannabis in relation to its delta'-trans-tetrahydro-cannabinol content.
Topics: Animals; Biological Assay; Cannabis; Catalepsy; Dronabinol; Drug Synergism; Female; Humans; Mice; Plant Extracts; Time Factors | 1981 |
Tetrahydrocannabinol potentiates reserpine-induced hypokinesia.
Topics: Animals; Antiparkinson Agents; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Humans; Male; Motor Activity; Rats; Rats, Inbred Strains; Reserpine; Time Factors | 1981 |
9 alpha, 10 alpha-epoxyhexahydrocannabinol formation from delta 9-tetrahydrocannabinol by liver microsomes of phenobarbital-treated mice and its pharmacological activities in mice.
Topics: Animals; Anticonvulsants; Catalepsy; Dronabinol; Humans; Hypothermia; Male; Mice; Microsomes, Liver; Phenobarbital; Sleep | 1983 |
Development of tolerance and cross-tolerance to the cataleptogenic effects of delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice.
Topics: Animals; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Drug Tolerance; Humans; Male; Mice | 1983 |
Pharmacological activity of the basic fraction of marihuana whole smoke condensate alone and in combination with delta-9-tetrahydrocannabinol in mice.
Topics: Animals; Body Temperature; Cannabis; Catalepsy; Defecation; Dronabinol; Drug Combinations; Humans; Male; Mice; Motor Activity; Smoke; Urination | 1984 |
IL-1 beta and TNF alpha modulate delta 9-tetrahydrocannabinol-induced catalepsy in mice.
Topics: Animals; Antibodies; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Female; Interleukin-1; Interleukin-6; Mice; Mice, Inbred BALB C; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1995 |
A novel class of potent tetrahydrocannabinols (THCS): 2'-yne-delta 8- and delta 9-THCS.
Topics: Analgesics; Animals; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Hypothermia; Male; Mice; Mice, Inbred ICR; Motor Activity; Rats; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship | 1995 |
Variation of the alkyl side chain in delta 8-THC.
Topics: Analgesics; Animals; Binding, Competitive; Catalepsy; Cyclohexanols; Dronabinol; Hypothermia; Mice; Motor Activity; Structure-Activity Relationship | 1995 |
Effect of dizocilpine (MK-801) on the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
Topics: Acetylcholine; Animals; Catalepsy; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dronabinol; Haloperidol; Male; Mice; Oxotremorine; Parkinson Disease; Receptors, N-Methyl-D-Aspartate | 1994 |
Repeated stimulation of D1 dopamine receptors enhances (-)-11-hydroxy-delta 8-tetrahydrocannabinol-dimethyl-heptyl-induced catalepsy in male rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Catalepsy; Dopamine Agents; Dronabinol; Drug Administration Schedule; Drug Synergism; Ergolines; Male; Motor Activity; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Stimulation, Chemical; Time Factors | 1994 |
Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
Topics: 2-Amino-5-phosphonovalerate; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amantadine; Amino Acids; Animals; Anticonvulsants; Catalepsy; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Ergolines; Haloperidol; Male; Mice; Mice, Inbred Strains; Motor Activity; Piperazines; Quinpirole; Receptors, N-Methyl-D-Aspartate; Scopolamine | 1994 |
delta 9-Tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats.
Topics: Amides; Animals; Arachidonic Acids; Catalepsy; Dronabinol; Drug Synergism; Endocannabinoids; Fatty Acids, Unsaturated; Globus Pallidus; Injections, Intraventricular; Muscimol; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley | 1993 |
In vitro metabolic formation of a new metabolite, 6 beta-hydroxymethyl-delta 9-tetrahydrocannabinol from cannabidiol through an epoxide intermediate and its pharmacological effects on mice.
Topics: Analgesics; Animals; Biotransformation; Body Temperature; Cannabidiol; Catalepsy; Dronabinol; Epoxy Compounds; Guinea Pigs; In Vitro Techniques; Male; Mice; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Sleep | 1993 |
A novel metabolite, an oxepin formed from cannabidiol with guinea-pig hepatic microsomes.
Topics: Animals; Cannabidiol; Catalepsy; Dibenzoxepins; Dronabinol; Gas Chromatography-Mass Spectrometry; Guinea Pigs; Hypothermia; Male; Mice; Microsomes, Liver; Oxepins; Sleep | 1995 |
Neurobehavioral effects of delta 9-THC and cannabinoid (CB1) receptor gene expression in mice.
Topics: Animals; Anxiety; Base Sequence; Behavior, Animal; Body Temperature; Catalepsy; Dronabinol; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred ICR; Molecular Sequence Data; Motor Activity; Polymerase Chain Reaction; Rats; Reaction Time; Receptors, Cannabinoid; Receptors, Drug; Species Specificity; Stereotaxic Techniques | 1995 |
The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord.
Topics: Analgesia; Analgesics; Animals; Body Temperature; Calcium; Catalepsy; Dronabinol; Drug Synergism; Dynorphins; Male; Mice; Morphine; Rabbits; Receptors, Opioid, delta; Receptors, Opioid, kappa; Spinal Cord | 1996 |
Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol.
Topics: Animals; Body Temperature Regulation; Cannabinoids; Catalepsy; Cyclohexanols; Dronabinol; Male; Maze Learning; Mice; Mice, Inbred ICR; Motor Activity; Nitrogen Mustard Compounds; Pain; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship | 1996 |
Interaction of dexanabinol (HU-211), a novel NMDA receptor antagonist, with the dopaminergic system.
Topics: Animals; Catalepsy; Cells, Cultured; Cerebral Cortex; Cyclic AMP; Dizocilpine Maleate; Dopamine Antagonists; Dronabinol; Excitatory Amino Acid Antagonists; Male; Mice; Mice, Inbred BALB C; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate | 1997 |
Synthesis and pharmacological activities in mice of halogenated delta 9-tetrahydrocannabinol derivatives.
Topics: Animals; Catalepsy; Dronabinol; Hallucinogens; Halogens; Hypothermia, Induced; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Motor Activity; Seizures; Sleep; Structure-Activity Relationship | 1998 |
High times for cannabis research.
Topics: Analgesics, Non-Narcotic; Animals; Cannabis; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Mice; Mice, Knockout; Motor Activity; Pain Threshold; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 1999 |
Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment.
Topics: Action Potentials; Animals; Body Temperature; Catalepsy; Dopamine; Dronabinol; Male; Motor Activity; Neurons; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Substantia Nigra; Ventral Tegmental Area | 2000 |
Activational role of cannabinoids on movement.
Topics: Animals; Cannabinoids; Catalepsy; Dose-Response Relationship, Drug; Dronabinol; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug | 2000 |
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor.
Topics: Animals; Body Temperature; Catalepsy; Cyclohexanols; Dronabinol; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, Cannabinoid; Receptors, Drug; T-Lymphocytes | 2000 |
delta9-Tetrahydrocannabinol and the extrapyramidal system.
Topics: Animals; Basal Ganglia; Behavior, Animal; Catalepsy; Caudate Nucleus; Dextroamphetamine; Dronabinol; Extrapyramidal Tracts; Globus Pallidus; Humans; Male; Motor Activity; Paralysis; Parasympathomimetics; Putamen; Rats; Spiro Compounds; Stereotyped Behavior; Succinimides | 1977 |
Catalepsy induced by intrastriatal injections of delta9-THC and 11-OH-delta9-THC in the rat.
Topics: Animals; Catalepsy; Corpus Striatum; Dextroamphetamine; Dronabinol; Drug Interactions; Humans; Injections; Male; Parasympathomimetics; Rats; Spiro Compounds; Succinimides; Trypan Blue | 1978 |
Synthesis and pharmacological activity of a phosphate ester of delta8-tetrahydrocannabinol.
Topics: Alkaline Phosphatase; Animals; Body Temperature; Catalepsy; Dronabinol; Drug Synergism; Humans; Lethal Dose 50; Liver; Male; Mice; Sleep; Thiopental; Time Factors | 1978 |
The oral activity of delta'-tetrahydrocannabinol and its dependence on prostaglandin E2.
Topics: Animals; Cannabidiol; Catalepsy; Chlorpromazine; Dronabinol; Drug Interactions; Humans; Male; Mice; Prostaglandin Antagonists; Prostaglandins E; Time Factors | 1979 |
The gamma-aminobutyric acid system in rat cerebellum during cannabinoid-induced cataleptoid state.
Topics: Aminobutyrates; Animals; Cannabis; Catalepsy; Cerebellum; Dronabinol; Female; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Humans; Male; Nerve Endings; Rats | 1975 |
Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by delta 9-THC in the rat.
Topics: Animals; Catalepsy; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Haloperidol; Male; Morphine; Nervous System; Rats; Rats, Inbred Strains; Time Factors | 1992 |
Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia.
Topics: Analgesia; Analysis of Variance; Animals; Body Temperature; Body Temperature Regulation; Brain; Catalepsy; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Dronabinol; Injections, Intravenous; Injections, Spinal; Male; Mice; Mice, Inbred ICR; Motor Activity; Pain; Spinal Cord; Tissue Distribution | 1992 |
Quantitation of rodent catalepsy by a computer-imaging technique.
Topics: Animals; Catalepsy; Dronabinol; Image Processing, Computer-Assisted; Male; Mice; Mice, Inbred ICR; Rats; Rats, Sprague-Dawley; Regression Analysis | 1992 |
Drugs which stimulate or facilitate central cholinergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice.
Topics: Acetylcholine; Animals; Atropine; Atropine Derivatives; Body Temperature; Catalepsy; Dronabinol; Drug Synergism; Male; Mice; Mice, Inbred Strains; Neostigmine; Oxotremorine; Parasympathomimetics; Physostigmine; Scopolamine; Synaptic Transmission | 1991 |
Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids.
Topics: Animals; Behavior, Animal; Cannabinoids; Catalepsy; Chlordiazepoxide; Dronabinol; Drug Interactions; Globus Pallidus; Injections; Injections, Intravenous; Male; Rats; Rats, Inbred Strains | 1991 |
The evaluation of synthetic cannabimimetic congeners for discriminative stimulus and cataleptogenic effects in rats.
Topics: Animals; Cannabinoids; Catalepsy; Discrimination, Psychological; Dronabinol; Rats | 1990 |
Pharmacological evaluation of halogenated delta 8-THC analogs.
Topics: Analgesics; Animals; Binding, Competitive; Body Temperature; Catalepsy; Cyclohexanols; Dronabinol; Male; Mice; Mice, Inbred ICR; Motor Activity; Receptors, Cannabinoid; Receptors, Drug | 1991 |
G-protein mediation of cannabinoid-induced phospholipase activation.
Topics: Adenylate Cyclase Toxin; Animals; Arachidonic Acid; Cannabinoids; Catalepsy; Dronabinol; Enzyme Activation; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Diphosphate; In Vitro Techniques; Macrophages; Mice; Pertussis Toxin; Phospholipases; Saponins; Thionucleotides; Virulence Factors, Bordetella | 1991 |
Immunization against prostaglandins reduces delta 1-tetrahydrocannabinol-induced catalepsy in mice.
Topics: Animals; Catalepsy; Dinoprostone; Dronabinol; Female; Immunization; Mice | 1989 |
Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs.
Topics: Animals; Body Temperature Regulation; Catalepsy; Dogs; Dronabinol; Male; Mice; Mice, Inbred ICR; Motor Activity; Reaction Time; Stereoisomerism | 1989 |
[Comparison between the catalepsies induced by delta 9-tetrahydro-cannabinol and haloperidol in rats].
Topics: Animals; Catalepsy; Dronabinol; Female; Haloperidol; Male; Rats | 1987 |
Delta-9-tetrahydrocannabinol-induced catalepsy in mice is enhanced by pretreatment with flurazepam or chlordiazepoxide.
Topics: Animals; Catalepsy; Chlordiazepoxide; Dronabinol; Drug Synergism; Flurazepam; Injections, Subcutaneous; Male; Mice; Postural Balance; Reflex; Time Factors | 1988 |
Drugs which stimulate or facilitate central GABAergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice.
Topics: Aminooxyacetic Acid; Animals; Baclofen; Bicuculline; Catalepsy; Dronabinol; Drug Synergism; Flumazenil; Flupenthixol; Flurazepam; GABA Antagonists; gamma-Aminobutyric Acid; Male; Mice; Muscimol; Nipecotic Acids; Receptors, GABA-A; Strychnine; Taurine; Tiagabine | 1988 |
Inhibition of the cataleptic effect of tetrahydrocannabinol by other constituents of Cannabis sativa L.
Topics: Animals; Cannabinoids; Cannabis; Catalepsy; Chromatography, Gas; Dronabinol; Male; Mice; Resorcinols | 1988 |
Pharmacological activities in the mouse of delta 9-tetrahydrocannabinol metabolites oxidized at the 8-position.
Topics: Animals; Biotransformation; Body Temperature; Catalepsy; Dronabinol; Humans; Male; Mice; Oxidation-Reduction; Pentobarbital; Sleep | 1985 |
[Behavioral pharmacology of amantadine with special references to the effect on abnormal behavior in mice and rats].
Topics: Aggression; Amantadine; Animals; Behavior, Animal; Catalepsy; Central Nervous System; Dronabinol; Haloperidol; Humans; Male; Methamphetamine; Mice; Motor Activity; Predatory Behavior; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1985 |
Noradrenergic involvement in catalepsy induced by delta 9-tetrahydrocannabinol.
Topics: Animals; Brain; Catalepsy; Desipramine; Dopamine; Dronabinol; Haloperidol; Hydroxydopamines; Locus Coeruleus; Male; Norepinephrine; Oxidopamine; Rats; Serotonin | 1987 |
A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice.
Topics: Animals; Catalepsy; Dinoprostone; Dronabinol; Epoprostenol; Female; Indomethacin; Mice; Prostaglandins E | 1987 |
Proceedings: Morphine-cannabinoid-interactions in rats and mice.
Topics: Analgesia; Animals; Behavior, Animal; Body Weight; Cannabis; Catalepsy; Dealkylation; Dronabinol; Drug Interactions; Humans; Mice; Morphine; Morphine Dependence; Naloxone; Rats; Time Factors | 1974 |
Modification of delta9-THC-actions by cannabinol and cannabidiol in the rat.
Topics: Animals; Benzopyrans; Body Temperature; Cannabis; Catalepsy; Dose-Response Relationship, Drug; Drinking; Dronabinol; Drug Antagonism; Drug Interactions; Drug Synergism; Eating; Hexobarbital; Humans; Male; Motor Activity; Rats; Resorcinols; Sleep; Terpenes; Time Factors | 1974 |
Brain levels of 1 -tetrahydrocannabinol and its metabolites in mice--correlation with behaviour, and the effect of the metabolic inhibitors SKF 525A and piperonyl butoxide.
Topics: Animals; Behavior, Animal; Brain Chemistry; Cannabis; Catalepsy; Chemical Phenomena; Chemistry; Chromatography, Paper; Chromatography, Thin Layer; Dioxoles; Dronabinol; Fats; Humans; Isotope Labeling; Male; Mice; Motor Activity; Pesticide Synergists; Piperonyl Butoxide; Proadifen; Solubility; Time Factors; Tritium | 1972 |
Antagonism of the effects of delta 9-tetrahydrocannabinol by pemoline (Cylert-4).
Topics: Analgesics; Animals; Behavior, Animal; Cannabis; Catalepsy; Crowding; Dronabinol; Drug Antagonism; Humans; Lethal Dose 50; Mice; Motor Activity; Pemoline; Reaction Time; Time Factors | 1973 |